• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

探索吡咯烷-芳基三唑亚氨基糖上的取代基多样性:β-葡糖脑苷脂酶抑制的结构基础。

Exploring substituent diversity on pyrrolidine-aryltriazole iminosugars: Structural basis of β-glucocerebrosidase inhibition.

机构信息

Department of Organic Chemistry, Faculty of Chemistry, University of Seville, C/Prof. García González, 1, 41012-Seville, Spain.

Department of Organic Chemistry, Faculty of Chemistry, University of Seville, C/Prof. García González, 1, 41012-Seville, Spain.

出版信息

Bioorg Chem. 2019 May;86:652-664. doi: 10.1016/j.bioorg.2019.02.025. Epub 2019 Feb 12.

DOI:10.1016/j.bioorg.2019.02.025
PMID:30825709
Abstract

The synthesis of a library of pyrrolidine-aryltriazole hybrids through CuAAC between two epimeric dihydroxylated azidomethylpyrrolidines and differently substituted phenylacetylenes is reported. The evaluation of the new compounds as inhibitors of lysosomal β-glucocerebrosidase showed the importance of the substitution pattern of the phenyl moiety in the inhibition. Crystallization and docking studies revealed key interactions of the pyrrolidine motif with aminoacid residues of the catalytic site while the aryltriazole moiety extended along a hydrophobic surface groove. Some of these compounds were able to increase the enzyme activity in Gaucher patient fibroblasts, acting as a new type of chemical chaperone for Gaucher disease.

摘要

通过两个差向异构的二羟基叠氮甲基吡咯烷与不同取代的苯乙炔之间的 CuAAC,合成了吡咯烷-芳基三唑杂合体文库。作为溶酶体β-葡糖苷脑苷脂酶抑制剂,新化合物的评估表明苯环取代模式对抑制作用的重要性。结晶和对接研究揭示了吡咯烷基模体与催化部位氨基酸残基的关键相互作用,而芳基三唑基沿疏水性表面槽延伸。这些化合物中的一些能够增加戈谢病患者成纤维细胞中的酶活性,作为戈谢病的一种新型化学伴侣。

相似文献

1
Exploring substituent diversity on pyrrolidine-aryltriazole iminosugars: Structural basis of β-glucocerebrosidase inhibition.探索吡咯烷-芳基三唑亚氨基糖上的取代基多样性:β-葡糖脑苷脂酶抑制的结构基础。
Bioorg Chem. 2019 May;86:652-664. doi: 10.1016/j.bioorg.2019.02.025. Epub 2019 Feb 12.
2
Synthesis of multimeric pyrrolidine iminosugar inhibitors of human β-glucocerebrosidase and α-galactosidase A: First example of a multivalent enzyme activity enhancer for Fabry disease.多聚吡咯烷亚氨基糖抑制剂的合成对人β-葡糖苷脑苷脂酶和α-半乳糖苷酶 A:法布里病的第一个多价酶活性增强剂实例。
Eur J Med Chem. 2020 Apr 15;192:112173. doi: 10.1016/j.ejmech.2020.112173. Epub 2020 Feb 20.
3
Docking study and biological evaluation of pyrrolidine-based iminosugars as pharmacological chaperones for Gaucher disease.基于吡咯烷的亚氨基糖作为戈谢病药理伴侣分子的对接研究及生物学评价
Org Biomol Chem. 2016 Jan 21;14(3):1039-48. doi: 10.1039/c5ob02223a. Epub 2015 Dec 3.
4
Structural basis of the inhibition of GH1 β-glucosidases by multivalent pyrrolidine iminosugars.多价吡咯烷亚氨基糖抑制 GH1 β-葡萄糖苷酶的结构基础。
Bioorg Chem. 2019 Aug;89:103026. doi: 10.1016/j.bioorg.2019.103026. Epub 2019 Jun 4.
5
Rapid modifications of N-substitution in iminosugars: development of new β-glucocerebrosidase inhibitors and pharmacological chaperones for Gaucher disease.快速修饰亚氨基糖中的 N-取代基:新型β-葡糖脑苷脂酶抑制剂和戈谢病药理学伴侣的开发。
Bioorg Med Chem. 2013 Sep 1;21(17):5021-8. doi: 10.1016/j.bmc.2013.06.054. Epub 2013 Jul 2.
6
Human Acid β-Glucosidase Inhibition by Carbohydrate Derived Iminosugars: Towards New Pharmacological Chaperones for Gaucher Disease.碳水化合物衍生的亚氨基糖对人酸性β-葡萄糖苷酶的抑制作用:迈向用于戈谢病的新型药理伴侣分子
Chembiochem. 2015 Sep 21;16(14):2054-64. doi: 10.1002/cbic.201500292.
7
α-Geminal disubstituted pyrrolidine iminosugars and their C-4-fluoro analogues: Synthesis, glycosidase inhibition and molecular docking studies.α-偕二取代吡咯烷亚氨基糖及其C-4-氟类似物:合成、糖苷酶抑制作用和分子对接研究。
Bioorg Med Chem. 2017 Oct 1;25(19):5148-5159. doi: 10.1016/j.bmc.2017.07.026. Epub 2017 Jul 14.
8
Iminosugar-Dihydroazulenes as Mutant L444P Glucocerebrosidase Enhancers.亚氨基糖-二氢薁作为 L444P 葡糖脑苷脂酶的突变增强剂。
Chem Biodivers. 2024 Aug;21(8):e202401104. doi: 10.1002/cbdv.202401104. Epub 2024 Jul 23.
9
Exploiting the hydrophobic terrain in fucosidases with aryl-substituted pyrrolidine iminosugars.利用含芳基取代吡咯烷亚氨基糖的岩藻糖苷酶中的疏水区域。
Chembiochem. 2015 Jan 19;16(2):277-83. doi: 10.1002/cbic.201402509. Epub 2014 Nov 26.
10
Tuning of β-glucosidase and α-galactosidase inhibition by generation and in situ screening of a library of pyrrolidine-triazole hybrid molecules.通过生成和原位筛选吡咯烷 - 三唑杂化分子文库对β - 葡萄糖苷酶和α - 半乳糖苷酶抑制作用的调节
Eur J Med Chem. 2017 Sep 29;138:532-542. doi: 10.1016/j.ejmech.2017.06.055. Epub 2017 Jun 27.

引用本文的文献

1
Evidence of α-Synuclein/Glucocerebrosidase Dual Targeting by Iminosugar Derivatives.亚氨基糖衍生物对α-突触核蛋白/葡萄糖脑苷脂酶的双重靶向作用的证据
ACS Chem Neurosci. 2025 Apr 2;16(7):1251-1257. doi: 10.1021/acschemneuro.4c00618. Epub 2025 Mar 13.
2
Multivalent Pyrrolidine Iminosugars: Synthesis and Biological Relevance.多价吡咯烷亚氨基糖:合成与生物学相关性。
Molecules. 2022 Aug 24;27(17):5420. doi: 10.3390/molecules27175420.
3
Structure-Based Identification and Biological Characterization of New NAPRT Inhibitors.基于结构的新型NAPRT抑制剂的鉴定与生物学特性研究
Pharmaceuticals (Basel). 2022 Jul 12;15(7):855. doi: 10.3390/ph15070855.
4
GCase Enhancers: A Potential Therapeutic Option for Gaucher Disease and Other Neurological Disorders.葡糖脑苷脂酶增强剂:戈谢病及其他神经疾病的一种潜在治疗选择。
Pharmaceuticals (Basel). 2022 Jul 2;15(7):823. doi: 10.3390/ph15070823.
5
Design, Synthesis and Structural Analysis of Glucocerebrosidase Imaging Agents.设计、合成与结构分析葡萄糖脑苷脂酶成像剂。
Chemistry. 2021 Nov 25;27(66):16377-16388. doi: 10.1002/chem.202102359. Epub 2021 Oct 29.
6
Glucocerebrosidase as a therapeutic target for Parkinson's disease.葡萄糖脑苷脂酶作为帕金森病的治疗靶点。
Expert Opin Ther Targets. 2020 Apr;24(4):287-294. doi: 10.1080/14728222.2020.1733970. Epub 2020 Feb 27.